奈米醫材

+2.10 (+3.00%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

72.1082成交張數36.60本益比1.79股價淨值比1.82%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度	單季 EPS	年增	近四季 EPS	歸屬母公司淨利(億)	淨利率	ROE(季)	ROE(近四季)
2026Q2	0.65	–	1.79	0.34	9.9%	1.82%	5.35%
2026Q1	0.74	-19.7%	0.81	0.38	12.8%	2.06%	2.35%
2025Q4	0.35	-40.4%	0.99	0.19	6.2%	1.03%	2.93%
2025Q3	0.05	-92.3%	1.23	0.02	0.9%	0.14%	3.81%
2025Q2	-0.33	-207.1%	1.83	-0.17	-6.3%	-1.03%	5.78%
2025Q1	0.92	106.9%	2.46	0.47	15.9%	2.80%	7.62%
2024Q4	0.59	–	1.99	0.31	11.9%	1.90%	6.37%
2024Q3	0.64	-24.1%	1.21	0.33	12.9%	2.05%	5.12%
2024Q2	0.31	-64.9%	1.41	0.16	8.7%	0.98%	5.44%
2024Q1	0.44	-22.2%	1.98	0.23	14.3%	1.44%	7.58%
2023Q4	-0.19	-136.8%	2.11	-0.06	-4.5%	-0.49%	7.96%
2023Q3	0.85	-19.7%	2.81	0.38	23.5%	3.89%	13.62%
2023Q2	0.88	46.9%	3.02	0.40	25.5%	4.50%	16.21%
2023Q1	0.57	-12.5%	2.74	0.26	17.6%	2.99%	15.46%
2022Q4	0.51	-11.5%	2.82	0.23	17.0%	2.67%	15.86%
2022Q3	1.06	175.0%	2.88	0.49	37.1%	5.88%	16.74%
2022Q2	0.60	211.5%	2.21	0.27	22.0%	3.56%	13.74%
2022Q1	0.65	388.7%	1.80	0.30	24.9%	3.96%	11.50%
2021Q4	0.58	–	1.29	0.26	23.2%	3.60%	8.30%
2021Q3	0.38	-22.4%	0.69	0.18	17.4%	2.54%	4.66%
2021Q2	0.19	29.9%	0.81	0.09	8.9%	1.25%	5.54%
2021Q1	0.13	-74.3%	0.76	0.06	7.4%	0.92%	5.30%
2020Q4	-0.01	-103.7%	1.15	-0.01	-1.0%	-0.11%	8.05%
2020Q3	0.50	-14.1%	1.56	0.23	23.8%	3.50%	11.08%
2020Q2	0.15	-77.5%	1.64	0.07	7.3%	1.05%	12.08%
2020Q1	0.52	218.2%	2.15	0.24	22.4%	3.76%	16.10%
2019Q4	0.40	184.3%	1.80	0.18	15.8%	2.90%	13.58%
2019Q3	0.58	44.4%	1.54	0.26	24.0%	4.25%	11.77%
2019Q2	0.66	–	–	0.30	23.5%	5.04%	–
2019Q1	0.16	–	–	0.07	10.4%	1.29%	–
2018Q4	0.14	–	–	0.07	10.3%	1.28%	–
2018Q3	0.40	–	–	0.18	22.5%	–	–